ATRA 8-K 2026-01-12

Atara Biotherapeutics, Inc. (ATRA) 8-K dated 2026-01-12 — accession 0001193125-26-010342. This URL is the filing, not the ATRA hub.

Atara Biotherapeutics, Inc. (ATRA) is a biotechnology company listed on NASDAQ.

Atara Biotherapeutics, Inc. filed a 8-K on 2026-01-12. Accession 0001193125-26-010342.

Cached items: 2.02, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ATRA revenue for 2025-12-31 was $120.8M. Net income was $32.7M. Revenue was down 6.3% from 2024-12-31 to 2025-12-31. ATRA currently screens at market cap $87.1M.

Not investment advice. The ATRA SEC hub lists recent forms. The stock page is the research view.